Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976298967> ?p ?o ?g. }
- W1976298967 abstract "Article4 April 2014free access Capping of the N-terminus of PSD-95 by calmodulin triggers its postsynaptic release Yonghong Zhang Department of Chemistry, University of California, Davis, CA, USA Search for more papers by this author Lucas Matt Department of Pharmacology, University of California, Davis, CA, USA Search for more papers by this author Tommaso Patriarchi Department of Pharmacology, University of California, Davis, CA, USA Department of Medical Genetics, University of Siena, Siena, Italy Search for more papers by this author Zulfiqar A Malik Department of Pharmacology, University of California, Davis, CA, USA Search for more papers by this author Dhrubajyoti Chowdhury Department of Pharmacology, University of California, Davis, CA, USA Search for more papers by this author Deborah K Park Department of Pharmacology, University of California, Davis, CA, USA Search for more papers by this author Alessandra Renieri Department of Medical Genetics, University of Siena, Siena, Italy Search for more papers by this author James B Ames Corresponding Author Department of Chemistry, University of California, Davis, CA, USA Search for more papers by this author Johannes W Hell Corresponding Author Department of Pharmacology, University of California, Davis, CA, USA Search for more papers by this author Yonghong Zhang Department of Chemistry, University of California, Davis, CA, USA Search for more papers by this author Lucas Matt Department of Pharmacology, University of California, Davis, CA, USA Search for more papers by this author Tommaso Patriarchi Department of Pharmacology, University of California, Davis, CA, USA Department of Medical Genetics, University of Siena, Siena, Italy Search for more papers by this author Zulfiqar A Malik Department of Pharmacology, University of California, Davis, CA, USA Search for more papers by this author Dhrubajyoti Chowdhury Department of Pharmacology, University of California, Davis, CA, USA Search for more papers by this author Deborah K Park Department of Pharmacology, University of California, Davis, CA, USA Search for more papers by this author Alessandra Renieri Department of Medical Genetics, University of Siena, Siena, Italy Search for more papers by this author James B Ames Corresponding Author Department of Chemistry, University of California, Davis, CA, USA Search for more papers by this author Johannes W Hell Corresponding Author Department of Pharmacology, University of California, Davis, CA, USA Search for more papers by this author Author Information Yonghong Zhang1,‡, Lucas Matt2,‡, Tommaso Patriarchi2,3,‡, Zulfiqar A Malik2, Dhrubajyoti Chowdhury2, Deborah K Park2, Alessandra Renieri3, James B Ames 1 and Johannes W Hell 2 1Department of Chemistry, University of California, Davis, CA, USA 2Department of Pharmacology, University of California, Davis, CA, USA 3Department of Medical Genetics, University of Siena, Siena, Italy ‡These authors contributed equally. *Corresponding author. Tel: +1 530 752 6358; Fax: +1 530 752 8995; E-mail: [email protected] *Corresponding author. Tel: +1 530 752 6540; Fax: +1 530 752 7710; E-mail: [email protected] EMBO J (2014)33:1341-1353https://doi.org/10.1002/embj.201488126 See also: T Saneyoshi & Y Hayashi (June 2014) PDFDownload PDF of article text and main figures. Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Abstract Postsynaptic density protein-95 (PSD-95) is a central element of the postsynaptic architecture of glutamatergic synapses. PSD-95 mediates postsynaptic localization of AMPA receptors and NMDA receptors and plays an important role in synaptic plasticity. PSD-95 is released from postsynaptic membranes in response to Ca2+ influx via NMDA receptors. Here, we show that Ca2+/calmodulin (CaM) binds at the N-terminus of PSD-95. Our NMR structure reveals that both lobes of CaM collapse onto a helical structure of PSD-95 formed at its N-terminus (residues 1–16). This N-terminal capping of PSD-95 by CaM blocks palmitoylation of C3 and C5, which is required for postsynaptic PSD-95 targeting and the binding of CDKL5, a kinase important for synapse stability. CaM forms extensive hydrophobic contacts with Y12 of PSD-95. The PSD-95 mutant Y12E strongly impairs binding to CaM and Ca2+-induced release of PSD-95 from the postsynaptic membrane in dendritic spines. Our data indicate that CaM binding to PSD-95 serves to block palmitoylation of PSD-95, which in turn promotes Ca2+-induced dissociation of PSD-95 from the postsynaptic membrane. Synopsis Ca2+ influx promotes Ca2+/calmodulin binding to the N-terminus of PSD-95, which blocks PSD-95 palmitoylation leading to reduced retention of PSD-95 at synapses. This effect will likely decrease postsynaptic glutamate receptor content and thereby synaptic strength. Ca2+/calmodulin forms a collapsed structure around the N-terminal helix of PSD-95 that sequesters the palmitoylation sites (Cys3 and Cys5) and a key tyrosine (Tyr12). Binding of Ca2+/calmodulin to the N-terminus of PSD-95 decreases its palmitoylation to release PSD-95 from postsynaptic sites Binding of Ca2+/calmodulin also displaces the serine/threonine kinase CDKL5 from PSD-95, which otherwise helps augment synaptic strength A point mutation of PSD-95 that prevents Ca2+/calmodulin binding turns the Ca2+-induced reduction in PSD-95 at synapses into an increase, uncovering the existence of a second mechanism that augments postsynaptic PSD-95 enrichment upon Ca2+ influx. Introduction The vast majority of synapses in the brain use glutamate as neurotransmitter (Micheva et al, 2010). It activates postsynaptic AMPA-type glutamate receptors (AMPARs) that are precisely juxtaposed to its presynaptic release site. Periods of heightened synaptic activity lead to activation of NMDA-type glutamate receptors (NMDARs). NMDARs mediate Ca2+ influx that can permanently increase the postsynaptic strength causing long-term potentiation (LTP; Lisman & Hell, 2008; Nicoll & Roche, 2013), which is most likely the physiological basis of learning and memory (Morris, 2013). A critical player in postsynaptic AMPAR targeting is PSD-95 (El-Husseini et al, 2000, 2002; Elias et al, 2006; Schluter et al, 2006). PSD-95 consists of three PDZ domains followed by an SH3 domain and a guanylate kinase homology domain (GK). PSD-95 anchors AMPARs at postsynaptic sites by binding with its first and second PDZ domains to the intracellular C-termini of auxiliary subunits known as transmembrane AMPAR regulatory proteins (TARPs), which include stargazin (Stg, γ2) and its homologs γ3, γ4, and γ8 (Chen et al, 2000; Schnell et al, 2002; Opazo et al, 2010). Furthermore, PSD-95 is palmitoylated at two cysteine residues (C3 and C5) at its N-terminus, which is required for its postsynaptic localization and for postsynaptic targeting of AMPARs (El-Husseini et al, 2002). Ca2+ influx through NMDARs causes PSD-95 to be temporarily released from postsynaptic membranes (Sturgill et al, 2009; Nelson et al, 2013). This release seems to reflect an important step for postsynaptic restructuring leading to enlargement of the postsynaptic site and thereby for an increase in postsynaptic AMPARs during LTP (Sturgill et al, 2009). Ultimately, PSD-95 augments postsynaptic AMPAR localization upon Ca2+ influx during LTP in part due to stimulation of phosphorylation of the C-terminus of Stg/γ2 upon NMDAR-mediate Ca2 influx by the Ca2/calmodulin (CaM)-dependent kinase CaMKII. This phosphorylation fosters membrane detachment of the C-terminus of Stg/γ2 and thereby binding of the very C-terminus of Stg/γ2 to PSD-95 (Tomita et al, 2005; Sumioka et al, 2010). The initial mobilization of PSD-95 upon Ca2 influx could either be necessary for structural plasticity to occur or constitute a negative feedback mechanism to curb potentiation. Ca2+/CaM interacts with PSD-95 and its homologs SAP97 and SAP102 in a Ca2-dependent manner (Masuko et al, 1999; Paarmann et al, 2002; Fukunaga et al, 2005) and stimulates PSD-95 binding to the non-receptor tyrosine kinase Pyk2 to augment NMDAR activity and thereby LTP (Bartos et al, 2010). Previous studies focused on the HOOK region at the C-terminal end of the SH3 domain of PSD-95, SAP97, and SAP102 as the CaM-binding site. We now report that Ca2+/CaM binds not only to the SH3 domain but also to the N-terminal region of PSD-95 as well as the second PDZ domain (PDZ2, residues 155–249). We present the NMR structure of Ca2+/CaM bound to the N-terminal region of a PSD-95 fragment [residues 1–71, called PSD-95(1–71)]. Both CaM lobes collapse around an N-terminal helix of PSD-95 (residues 1–16) and sequester two palmitoylation sites (C3 and C5) that mediate postsynaptic targeting of PSD-95. CaM forms extensive contacts with Y12 in PSD-95, and mutating Y12 to Glu prevents binding of CaM to PSD-95 upon Ca2+ influx. Importantly, although this mutation does not affect PSD-95 palmitoylation under basal conditions, it counteracts the reduction in palmitoylation of PSD-95 following Ca2+ influx and the Ca2+-induced release of PSD-95 from postsynaptic membranes. It also blocks displacement of CDKL5, which binds to the N-terminus of palmitoylated PSD-95 (Zhu et al, 2013) and can strengthen postsynaptic responses (Ricciardi et al, 2012; Zhu et al, 2013). Our results identify the N-terminal CaM-binding site of PSD-95 as a critical regulator of the dynamic postsynaptic localization of PSD-95 and thereby of postsynaptic plasticity. Results CaM binds to the N-terminus of PSD-95 To characterize binding of CaM to PSD-95 beyond the established interaction between CaM and the SH3 domain of PSD-95, pull-down assays of CaM were performed with the various GST-tagged PSD-95 fragments (Fig 1A). Accordingly, Ca2+/CaM interacted with the N-terminal region of PSD-95 (residues 1–71 preceding PDZ1), PDZ2, and SH3 but not PDZ3, GK, or GST alone (Fig 1B and D). All samples contained comparable amounts of the respective full-length fusion protein with little to no degradation (Fig 1C). To define the CaM-binding site at the PSD-95 N-terminus more precisely, CaM binding to fluorescein-labeled peptides of residues 1–13, 15–36, 37–52, and 49–65 was monitored by fluorescence polarization (FP; Fig 2A and B). FP of the peptide spanning the first 13 residues showed saturable binding upon adding increasing amounts of CaM. Accordingly, this peptide binds to CaM with a dissociation constant of 18 ± 0.3 μM (Fig 2B, black circles). None of the other peptides (collectively covering residues 15–65) bound CaM at protein concentrations up to 100 μM (Fig 2B). These results indicate that CaM exhibits Ca2+-induced binding to the first 13 residues of PSD-95. Figure 1. Ca2+/calmodulin (CaM) binds to the N-terminus, PDZ2, and SH3 of PSD-95 Schematic diagram of PSD-95 domains depicting the N-terminal region (residues 1–64), PDZ1–3, SH3, and GK. Pull-down of Ca2+-bound CaM with the various PSD-95 domains. Probing for GST to visualize fusion proteins on a blot run in parallel to the pull-down blot. Relative band intensities from (B) are shown for each PSD-95 domain as determined by densitometry from 11 independent experiments. Download figure Download PowerPoint Figure 2. N-terminal 13 residues of PSD-95 bind to Ca2+/CaM Amino acid sequence of the N-terminal 65 residues of PSD-95. Rectangular boxes underneath define the length of synthetic peptide fragments used in binding assays with Ca2+/CaM. Palmitoylation sites are highlighted in orange. Fluorescence polarization (FP; see 4) from each synthetic peptide covalently labeled with fluorescein is plotted as a function of CaM concentration. The increase in FP from the N-terminal peptide (residues 1–13) as a function of increasing CaM concentration indicates binding. The Kd for binding of Ca2+/CaM to the N-terminal peptide is calculated to be 18 μM. None of the other peptides showed any increase in FP as a function of increasing CaM concentration (up to 100 μM), indicating that these peptides do not bind to Ca2+/CaM. Peptide alanine scanning spot array of N-terminal PSD-95 peptide (residues 1–13) for Ca2+/CaM binding. Mutagenesis of PSD-95 residues highlighted in orange show the largest effect on CaM binding. Ca2+/CaM binding to mutant N-terminal PSD-95 peptides (residues 1–13; WT titration is same as in B). Binding of CaM mutants to N-terminal PSD-95 peptide (residues 1–13; WT titration is same as in B). Download figure Download PowerPoint CaM forms a collapsed structure around the N-terminal helix in PSD-95 NMR spectroscopy was used to characterize the structural interaction of CaM bound to PSD-95(1–71). The 15N-1H HSQC NMR spectrum of 15N-labeled PSD-95(1–71) in the absence of CaM exhibits poor chemical shift dispersion, indicative of an unstructured and random coil conformation (Fig 3A). The NMR assignments for PSD-95(1–71) were determined as shown in Fig 3A. The addition of saturating CaM causes the PSD-95 NMR peaks assigned to residues 1–16 to broaden significantly, whereas the NMR peaks assigned to residues 17–71 were unaffected by CaM. Thus, the CaM-binding site on PSD-95(1–71) is localized within the first 16 residues from the N-terminus, consistent with the results in Fig 2. Figure 3. NMR analysis of Ca2+/CaM binding to PSD-95 (1–71) Two-dimensional 15N-1H HSQC spectra of 15N-labeled PSD-95(1–71) in the absence (red) and presence (green) of unlabeled Ca2+/CaM. The NMR resonances assigned to the N-terminal 16 residues in PSD-95 show as much as 100-fold decrease in peak height caused by CaM binding. The NMR assignments have been deposited in the BMRB (Accession Number 19238). The decreased NMR intensity is mostly due to chemical shift exchange broadening at these sites caused by CaM binding that has exchange kinetics on the chemical shift time scale. NMR signals assigned to PSD-95 residues 17–71 are unaffected by CaM binding. NMR resonance assigned to non-native residue (S0) upstream of the N-terminal Met is marked by an asterisk. 15N-1H HSQC spectra of 15N-labeled Ca2+/CaM in the absence (red) and presence (green) of unlabeled PSD-95(1–71). CaM residues that show the largest spectral changes caused by binding to PSD-95(1–71) are indicated by residue labels and are listed in Supplementary Table S1. Download figure Download PowerPoint The 15N-1H HSQC NMR spectrum of 15N-labeled Ca2+-free CaM does not change upon adding a 10-fold excess of PSD-95(1–71) (not shown), consistent with a lack of PSD-95 binding to apo-CaM. By contrast, the 15N-1H HSQC NMR spectrum of 15N-labeled Ca2+/CaM changes significantly upon adding a stochiometric amount of PSD-95(1–71) (Fig 3B). The spectral changes saturate after adding one equivalent of PSD-95(1–71), indicating a 1:1 binding stoichiometry. CaM residues in the N- and C-lobe exhibit amide NMR peaks that either broaden or change chemical shift upon adding PSD-95(1–71) (Supplementary Table S1), suggesting the respective CaM residues are at or near the PSD-95(1–71) binding site. Most of these residues are clustered in exposed hydrophobic patches on both CaM lobes. However, some CaM residues have NMR signals that are not affected by PSD-95(1–71), including residues in the EF-hand Ca2+-binding loops (G25, G61, G98, G134) and polar surface of the CaM lobes (E7, K13, K30, E114). The lack of chemical shift changes to these residues suggests that the internal main chain structure within each lobe does not change much upon binding to PSD-95(1–71) and target binding is localized mainly to the exposed hydrophobic sites on both CaM lobes. A detailed protocol for determining the NMR structure of the CaM/PSD-95(1–71) complex is summarized in Supplementary Methods. Residual dipolar couplings (RDCs, Supplementary Fig S1 and Table S2; Tjandra & Bax, 1997) and chemical shift perturbation data (Supplementary Table S1) provided structural restraints for a molecular docking calculation using the software HADDOCK (de Vries et al, 2010). Ten lowest energy structures of the CaM/PSD-95 complex are superimposed in Fig 4A and have a main chain RMSD of 0.69 Ǻ (structural statistics in Table 1). The energy-minimized average main chain structure is shown in Fig 4B. Table 1. Structure statistics for NMR-derived structures of Ca2+/calmodulin (CaM)/PSD95-NT complex Parameter Value NMR restraints Short-range NOEs 12 Dihedral angles 46 Hydrogen bonds 34 Ambiguous interaction restraints (AIR) 69 1DHN RDC 78 RDC Q-factoraa Q-factor = RMS(Dcalc − Dobs)/RMS(Dobs), where Dcalc and Dobs are calculated and observed residual dipolar couplings (RDC) values, respectively. 0.11 Ramachandran plot Most favored region (%) 86.3 Allowed region (%) 13.7 Disallowed region (%) 0.0 RMSD from average structure (Å) CaM backbone atoms 0.59 PSD95 (1–19) backbone atoms 0.70 All backbone atoms 0.69 a Q-factor = RMS(Dcalc − Dobs)/RMS(Dobs), where Dcalc and Dobs are calculated and observed residual dipolar couplings (RDC) values, respectively. Figure 4. Ca2+/CaM forms a collapsed structure around the N-terminal helix of PSD-95 A. Superposition of main chain atoms of 10 lowest energy NMR-derived structures of CaM (red) bound to the N-terminal helix in PSD-95 (cyan). Bound Ca2+ is depicted in yellow. The atomic coordinates have been deposited into the Protein Databank (2MES). B. Ribbon representation of the energy-minimized average main chain structure of CaM (N-lobe: pink, C-lobe: red) bound to the N-terminal helix of PSD-95 (cyan). The four EF-hands in CaM are labeled EF1, EF2, EF3, and EF4. Side-chain atoms of CaM residues (L39 and V108) show contact between N-lobe (pink) and C-lobe (red). C, D. Close-up view of exposed side-chain atoms in CaM (red) interacting with side-chain atoms from PSD-95 residues C3, C5, I6, Y12 and R13 (C) or L4, V7 and K10 (D). Salt bridges to PSD-95 K10 and R13 are depicted by dashed lines. Download figure Download PowerPoint The NMR-derived structure of the CaM/PSD-95(1–71) complex reveals that both lobes of CaM collapse around the N-terminal helix of PSD-95 (residues 1–16) (Fig 4B). The helical structure of the first 16 residues of PSD-95 in the complex was confirmed by circular dichroism (Supplementary Fig S2). Several hydrophobic residues in PSD-95 including L4, I6, V7, and Y12 interact with exposed hydrophobic residues of CaM (Fig 4C and D). Most striking are the two palmitoylation sites (C3 and C5; El-Husseini et al, 2002, 2000) in PSD-95 that are completely sequestered by hydrophobic residues in the N-lobe of CaM (F19, L32 and L39). Also noteworthy is that PSD-95 Y12 fits into a cavity formed by CaM residues in the C-lobe (M124, E127, V136, F141, and M144). In addition to hydrophobic contacts, PSD-95 K10 forms a salt bridge with CaM E11, which might play a role in specifying the orientation of the PSD-95 helix bound to CaM, and PSD-95 R13 forms salt bridges with E114 and E120 of CaM. The two lobes of CaM in the complex form interdomain contacts between L39 and V108 (Fig 4B, N-lobe: pink and C-lobe: red), which stabilize a collapsed structure of CaM as seen in previous structures of CaM bound to various target proteins (Hoeflich & Ikura, 2002). The EF-hand interhelical angles for CaM bound to PSD-95 are typical for Ca2+-bound EF-hands in the familiar open conformation (87˚ from EF1, 106˚ for EF2, 91˚ for EF3 and 97˚ for EF4). Our structural model of CaM bound to the PSD-95 N-terminus reveals that the two palmitoylation sites in PSD-95 (C3 and C5) are almost completely buried by CaM and therefore not accessible. To test whether CaM blocks the accessibility of C3 and C5, we monitored whether CaM can inhibit the covalent attachment of a fluorescent dye (fluorescein-5-maleimide) at both C3 and C5 in PSD-95(1–71). This modification should mimic the attachment of palmitate at these sites. Fluorescein-5-maleimide is a thiol-reactive molecular probe that should specifically attach to both C3 and C5 in PSD-95(1–71). The dye was added to PSD-95(1–71) with no CaM, Ca2+/CaM, or apo-CaM. After removing unreacted dye, fluorescence emission spectra were recorded for each sample (Supplementary Fig S3A). Fluorescence was 50% less following incubation in the presence of Ca2+/CaM compared with no CaM or apo-CaM. These results indicate that Ca2+/CaM decreases the efficiency with which the fluorescein dye is attached to PSD-95 likely by blocking the accessibility of the two cysteines. PSD-95 will spend some fraction of time free of CaM even in the presence of stoichiometric amounts of Ca2+/CaM, which would allow fluorescein attachment of PSD-95 to build up over time and could explain partial rather than full block of fluorescein attachment. To further demonstrate that Ca2+/CaM binding and palmitoylation of C3 and C5 in PSD-95 are mutually exclusive, we examined whether the attachment of fluorescein at C3 and C5 might prevent binding of Ca2+/CaM. Indeed, the 15N-1H HSQC NMR spectrum of 15N-labeled CaM does not substantially change upon adding a stoichiometric amount of fluorescein-labeled PSD-95(1–71) (Supplementary Fig S3B) in contrast to the dramatic change upon addition of a stoichiometric amount of unconjugated PSD-95(1–71) (Fig 3B). These results show that Ca2+/CaM binds preferentially to unconjugated PSD-95(1–71), consistent with binding of Ca2+/CaM to depalmitoylated but not palmitoylated PSD-95. Mutagenesis of CaM/PSD-95 structural interface weakens binding To validate the NMR structural model of the CaM/PSD-95 complex, Ala scanning was performed through the peptide that covers the first 13 N-terminal residues of PSD-95. Peptides were spot synthesized on a membrane and probed by overlay with Ca2+/CaM, which was detected with an anti-CaM antibody (Fig 2C). Substitution of PSD-95 residues Y12 and R13 by Ala either individually or combined completely abolished binding to CaM in this assay, consistent with these residues making multiple contacts with CaM as seen in our structure (Fig 4C and D). Substitution of L4 with Ala also decreased the binding affinity to CaM at least when combined with two additional Ala substitutions (Fig 2C), consistent with L4 making hydrophobic contacts with CaM (Fig 4D). However, triple Ala mutations of C5, I6 and V7 that form contacts with CaM did not substantially affect CaM binding (Fig 2C), perhaps because Ala is similar enough to these residues to retain binding. Instead of using Ala mutations, the PSD-95 residues (C3, C5, I6 and V7) were replaced with the more polar Glu for more quantitative analysis by FP. As expected, all of the Glu mutants (C3E, L4E, C5E, I6E and V7E) weaken CaM binding to PSD-95 (Fig 2D; Supplementary Table S3), consistent with each of these residues making hydrophobic contacts with CaM (Fig 4C and D). The CaM/PSD-95 structure was further validated by mutations in CaM. Mutagenesis of CaM residue L39 to Gly at the lobe interface (L39G) weakens binding to PSD-95 (Fig 2F; Supplementary Table S4). L39 in the CaM N-lobe forms hydrophobic contacts with V108 from the C-lobe that stabilizes interaction between the two lobes in the collapsed CaM/PSD-95 structure (Fig 4B). The L39G mutation abolishes the hydrophobic interaction with V108, which weakens contact between the two lobes and destabilizes the collapsing of the two lobes around the N-terminus of PSD-95. Thus, a cooperative interaction of both CaM lobes is necessary to create proper binding to PSD-95 and explains why residues from both the N-lobe and C-lobe participate in binding to PSD-95 (Fig 4C and D). The cooperativity of the lobes is also consistent with the observation that the individual CaM lobes (N-lobe: residues 1–77 and C-lobe: residues 82–148), which are structured (Zhang et al, 2012), cause no detectable change in the NMR spectrum of PSD-95(1–71) (Supplementary Fig S4), in contrast to the large spectral change induced by full-length CaM. PSD-95 residue Y12 forms extensive contacts with CaM (Fig 4C). The Y12E mutation disrupts hydrophobic interactions with CaM residues (M124, V136, F141, M144) and weakens the binding affinity by approximately 37-fold (Fig 2D; Supplementary Table S3). In addition to the hydrophobic contacts, the phenolic side chain of Y12 forms a hydrogen bond with the side-chain carboxyl group of CaM residue E127. The E127A mutation in CaM eliminates this hydrogen bond and weakens the binding affinity by 2.5-fold (Fig 2E; Supplementary Table S4), which in terms of free energy is consistent with the loss of a hydrogen bond, further confirming the CaM/PSD-95 structure. N-terminal Ca2+/CaM binding impairs PSD-95 palmitoylation and CDKL5 binding To test in intact cells whether Ca2+ influx negatively controls palmitoylation of PSD-95, HEK293 cells were transfected with PSD-95WT and PSD-95Y12E. Y12 makes multiple contacts with Ca2+/CaM, and changing it to Glu strongly impairs binding of Ca2+/CaM (Fig 2D and E). At the same time, this mutation should not affect basal palmitoylation of PSD-95 per se, because Y12 is not located in the palmitoyltransferase binding site (PSD-95 residues 3–9; El-Husseini et al, 2000; Fukata et al, 2004). Under basal conditions, PSD-95WT and PSD-95Y12E showed comparable levels of palmitoylation in HEK293 cells (Fig 5A and B). Normal basal PSD-95Y12E palmitoylation is also indicated by clustering of the ectopically expressed PSD-95WT and PSD-95Y12E when expressed in COS cells (Supplementary Fig S5), which requires palmitoylation (Hsueh & Sheng, 1999; El-Husseini et al, 2002; Fukata et al, 2013). Ca2+ influx mediated by the Ca2+ ionophore ionomycin induced a strong loss of palmitoylation of PSD-95WT but not PSD-95Y12E (Fig 5A), indicating that binding of Ca2+/CaM to the N-terminus of PSD-95 shifts PSD-95 toward its depalmitoylated state. Figure 5. Ca2+/CaM antagonizes palmitoylation of PSD-95 and CDKL5 binding in HEK293 cells A, B. HEK293T cells were transfected with RFP-PSD-95WT or RFP-PSD-95Y12E. After 24 h, cells were treated with vehicle (CT) or 5 μM ionomycin for 5 min and extracted. NEM was added to alkylate free SH groups on Cys. Palmitoylated Cys were deacylated with hydroxylamine (NH2OH), and newly available SH groups biotinylated for pull-down with streptavidin, followed by immunoblotting for PSD-95. Omission of NH2OH prevented pull-down (left lane) indicating the specificity of this procedure. Ionomycin-induced Ca2+ influx decreased palmitoylation of PSD-95WT but not PSD-95Y12E. Total levels of PSD-95WT and PSD-95Y12E were comparable as determined just before pull-down (Input). C–E. HEK293T cells were transfected with RFP-PSD-95WT or RFP-PSD-95Y12E plus CDKL5 for treatment as above, immunoprecipitation of PSD-95, and immunoblotting as indicated. Ionomycin-induced Ca2+ influx nearly abolished co-immunoprecipitation of CDKL5 with PSD-95WT but not PSD-95Y12E (C, E). Pre-treatment with CMZ (10 min, 30 μM) prevented loss of CDKL5 co-immunoprecipitation. Lack of PSD-95 and CDKL5 immunoprecipitation by control IgG shows specificity of their co-precipitation (C, left lane). Total expression of PSD-95WT and PSD-95Y12E and of CDKL5 in the various conditions was comparable (D; tubulin served as a loading control). Quantification (E) shows the ratio of CDKL5 co-precipitation versus PSD-95 content in each sample. Data information: In (B) and (E), data are given as means ± s.e.m., ***P < 0.001, one-way ANOVA with Dunnett's post-test. Download figure Download PowerPoint The cyclin-dependent protein kinase-like kinase CDKL5 binds to the first 19 residues of PSD-95 but only if PSD-95 is palmitoylated (Zhu et al, 2013). Because postsynaptic targeting of CDKL5 by this interaction augments postsynaptic strength (Zhu et al, 2013; see also Ricciardi et al, 2012), a functionally important question is whether this interaction is downregulated by Ca2+/CaM. HEK293 cells were co-transfected with PSD-95 and CDKL5 before treatment with ionomycin and co-immunoprecipitation of CDKL5 with PSD-95. As expected from its negative effect on palmitoylation, ionomycin disrupted the co-precipitation of CDKL5 with WT PSD-95 nearly completely (Fig 5C–E). This effect depended on Ca2+/CaM binding to PSD-95 as PSD-95Y12E did not show any loss of co-precipitation upon Ca2+ influx and the CaM antagonist calmidazolium (CMZ) prevented the Ca2+-induced loss of co-precipitation of WT PSD-95. To test whether Ca2+/CaM affects PSD-95 palmitoylation in intact neurons, acute forebrain slices were treated with 100 μM NMDA for 5 min. This treatment triggers postsynaptic Ca2+ influx that stimulates recruitment of CaMKII to NMDARs and subsequent phosphorylation of the AMPAR GluA1 subunit on S831 (Leonard et al, 1999 #551; Halt et al, 2012 #550). Postsynaptic Ca2+ influx had been shown earlier to reduce PSD-95 palmitoylation (El-Husseini et al, 2002). Accordingly, NMDA treatment reduced PSD-95 palmitoylation (Fig 6A and B). This effect is selective for palmitoylation of PSD-95 as palmitoylation of Gαi3 was unaffected (Fig 6A). NMDA induced in parallel association of Ca2+/CaM with PSD-95 and displacement of CDKL5 from PSD-95 (Fig 6C–E). Importantly, three different CaM antagonists [CMZ, trifluoperazine (TFP), W7] prevented the loss of palmitoylation and of CDKL5 co-precipitation and the increase in CaM co-precipitation. We conclude that NMDAR-mediated Ca2+ influx induces CaM binding to PSD-95, thereby reducing both, palmitoylation of PSD-95 and CDKL5 displacement in neurons. Figure 6. Ca2+/CaM antagonizes palmitoylation of PSD-95 and CDKL5 binding in neuronsAcute forebrain slices were treated with vehicle (CT)" @default.
- W1976298967 created "2016-06-24" @default.
- W1976298967 creator A5000927314 @default.
- W1976298967 creator A5008529621 @default.
- W1976298967 creator A5029091929 @default.
- W1976298967 creator A5031514544 @default.
- W1976298967 creator A5053171214 @default.
- W1976298967 creator A5057047177 @default.
- W1976298967 creator A5064306128 @default.
- W1976298967 creator A5065616575 @default.
- W1976298967 creator A5068947466 @default.
- W1976298967 date "2014-04-04" @default.
- W1976298967 modified "2023-10-12" @default.
- W1976298967 title "Capping of the N-terminus of PSD-95 by calmodulin triggers its postsynaptic release" @default.
- W1976298967 cites W1487695731 @default.
- W1976298967 cites W1570346075 @default.
- W1976298967 cites W1796178200 @default.
- W1976298967 cites W1963811715 @default.
- W1976298967 cites W1963928863 @default.
- W1976298967 cites W1964945221 @default.
- W1976298967 cites W1965608446 @default.
- W1976298967 cites W1967305385 @default.
- W1976298967 cites W1975255652 @default.
- W1976298967 cites W1975306052 @default.
- W1976298967 cites W1977873923 @default.
- W1976298967 cites W1981522895 @default.
- W1976298967 cites W1984617454 @default.
- W1976298967 cites W1989172408 @default.
- W1976298967 cites W1991131678 @default.
- W1976298967 cites W1994236320 @default.
- W1976298967 cites W1997956229 @default.
- W1976298967 cites W1999024554 @default.
- W1976298967 cites W2018458016 @default.
- W1976298967 cites W2022582268 @default.
- W1976298967 cites W2024015768 @default.
- W1976298967 cites W2027844417 @default.
- W1976298967 cites W2035460326 @default.
- W1976298967 cites W2035949896 @default.
- W1976298967 cites W2042210724 @default.
- W1976298967 cites W2043643572 @default.
- W1976298967 cites W2044087866 @default.
- W1976298967 cites W2044207008 @default.
- W1976298967 cites W2048559110 @default.
- W1976298967 cites W2053538195 @default.
- W1976298967 cites W2057269307 @default.
- W1976298967 cites W2065359670 @default.
- W1976298967 cites W2068612489 @default.
- W1976298967 cites W2069863147 @default.
- W1976298967 cites W2073486807 @default.
- W1976298967 cites W2076508109 @default.
- W1976298967 cites W2079827686 @default.
- W1976298967 cites W2082411508 @default.
- W1976298967 cites W2084344997 @default.
- W1976298967 cites W2086871275 @default.
- W1976298967 cites W2090694271 @default.
- W1976298967 cites W2097771231 @default.
- W1976298967 cites W2100064902 @default.
- W1976298967 cites W2114985678 @default.
- W1976298967 cites W2120385383 @default.
- W1976298967 cites W2129879061 @default.
- W1976298967 cites W2139503851 @default.
- W1976298967 cites W2143221073 @default.
- W1976298967 cites W2166353621 @default.
- W1976298967 cites W2168234829 @default.
- W1976298967 cites W3103710998 @default.
- W1976298967 cites W585835727 @default.
- W1976298967 cites W83352589 @default.
- W1976298967 cites W2594178584 @default.
- W1976298967 doi "https://doi.org/10.1002/embj.201488126" @default.
- W1976298967 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4194123" @default.
- W1976298967 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24705785" @default.
- W1976298967 hasPublicationYear "2014" @default.
- W1976298967 type Work @default.
- W1976298967 sameAs 1976298967 @default.
- W1976298967 citedByCount "42" @default.
- W1976298967 countsByYear W19762989672014 @default.
- W1976298967 countsByYear W19762989672015 @default.
- W1976298967 countsByYear W19762989672016 @default.
- W1976298967 countsByYear W19762989672017 @default.
- W1976298967 countsByYear W19762989672018 @default.
- W1976298967 countsByYear W19762989672019 @default.
- W1976298967 countsByYear W19762989672020 @default.
- W1976298967 countsByYear W19762989672021 @default.
- W1976298967 countsByYear W19762989672022 @default.
- W1976298967 countsByYear W19762989672023 @default.
- W1976298967 crossrefType "journal-article" @default.
- W1976298967 hasAuthorship W1976298967A5000927314 @default.
- W1976298967 hasAuthorship W1976298967A5008529621 @default.
- W1976298967 hasAuthorship W1976298967A5029091929 @default.
- W1976298967 hasAuthorship W1976298967A5031514544 @default.
- W1976298967 hasAuthorship W1976298967A5053171214 @default.
- W1976298967 hasAuthorship W1976298967A5057047177 @default.
- W1976298967 hasAuthorship W1976298967A5064306128 @default.
- W1976298967 hasAuthorship W1976298967A5065616575 @default.
- W1976298967 hasAuthorship W1976298967A5068947466 @default.
- W1976298967 hasBestOaLocation W19762989671 @default.
- W1976298967 hasConcept C104317684 @default.
- W1976298967 hasConcept C12554922 @default.
- W1976298967 hasConcept C14053116 @default.
- W1976298967 hasConcept C167625842 @default.